Showing results (331-340 of 26,310) with videos related to
Sort By:
Pageof 2,631
Bioorganic & Medicinal Chemistry Letters|June 4, 2015
Syntheses and evaluation of substituted aromatic hydroxamates and hydroxamic acids that target Mycobacterium tuberculosisMark W Majewski, Sanghyun Cho, Patricia A Miller, et al.Bioorganic & Medicinal Chemistry Letters|June 6, 2015
Recent trends in orexin research--2010 to 2015Christoph Boss, Catherine RochBioorganic & Medicinal Chemistry Letters|February 11, 2025
Isolation, synthesis and structure-activity relationships of gallotannin derivatives as cathepsin C inhibitorHung-Chen Liao, Liang-Mou Kuo, Wei-Ting Chen, et al.Bioorganic & Medicinal Chemistry Letters|February 13, 2025
Synthesis and evaluation of a novel bifunctional ligand 3o-C-NETA for Yttrium-90 and Lutetium-177Hua Xu, Pengfei Dong, Haixing Wang, et al.Bioorganic & Medicinal Chemistry Letters|February 26, 2025
Design, synthesis and biological evaluation of sulfur-containing tetrahydroxanthones as potential anti-tumor agentsHuimin Zheng, Youyi Wang, Yitao Ren, et al.Bioorganic & Medicinal Chemistry Letters|January 29, 2025
Synthesis and evaluation of KX-01 analogs with an exploration of linker attachment points for antibody-drug conjugatesYeju Oh, Da Eun An, Jaebeom Park, et al.Bioorganic & Medicinal Chemistry Letters|January 15, 2025
Synthesis of harmaline N-9 derivatives and investigation of in vitro anticancer activityYongjian Liu, Hao Liu, Shuqi Li, et al.Bioorganic & Medicinal Chemistry Letters|January 25, 2025
Novel isoxazole thiophene-containing compounds active against Mycobacterium tuberculosisGabrielle Martinez, Kirsten Tolentino, Paridhi Sukheja, et al.Bioorganic & Medicinal Chemistry Letters|January 10, 2025
Development of novel GI-centric prostaglandin E2 receptor type 4 (EP4) agonist prodrugs as treatment for ulcerative colitis and other intestinal inflammatory diseasesSrinivas Kantham, Hongbing Yu, Christophe R Cantelli, et al.Bioorganic & Medicinal Chemistry Letters|January 8, 2025
Structure guided modification of 2-chloro-5-(ethyl-phenyl-sulfamoyl)-N-[2-(2-oxo-pyrrolidin-1-yl)-phenyl]-benzamide to afford selective inhibitors of Cryptosporidium parvum N-myristoyltransferaseDilep K Sigalapalli, Sophia Groustra, Michael K Fenwick, et al.Pageof 2,631